Taking the long view: how to design a series of Phase III trials to maximize cumulative therapeutic benefit

Current sample size conventions: Flaws, harms, and alternatives

(2010) Peter Bacchetti   BMC Medicine

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

(2010) Eunice L. Kwak et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adaptive increase in sample size when interim results are promising: A practical guide with examples

(2010) Cyrus R. Mehta et al.   STATISTICS IN MEDICINE

Treatment Success in CancerNew Cancer Treatment Successes Identified in Phase 3 Randomized Controlled Trials Conducted by the National Cancer Institute–Sponsored Cooperative Oncology Groups, 1955 to 2006

(2008) Benjamin Djulbegovic   ARCHIVES OF INTERNAL MEDICINE

Cancer: The Road to Amiens

(2008) David J. Stewart et al.   JOURNAL OF CLINICAL ONCOLOGY

Decision-Making When Data and Inferences Are Not Conclusive: Risk-Benefit and Acceptable Regret Approach

(2008) Iztok Hozo et al.   SEMINARS IN HEMATOLOGY